Skip to main content
. Author manuscript; available in PMC: 2020 Sep 1.
Published in final edited form as: Best Pract Res Clin Haematol. 2019 Jun 6;32(3):196–206. doi: 10.1016/j.beha.2019.06.003

Figure 2. Rare leukemia cell lineage highlighting genomic differences from normal cell counterparts.

Figure 2.

A simplified T-cell hematopoietic lineage is shown, along with annotations indicating which cells represent the normal counterpart of a particular leukemia. Within each cancer cell, genomic aberrations that are known to cause increased JAK/STAT signaling along with other known mutations or gene rearrangements are listed.